Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics

PLoS Genetics

Volumn 2, Issue 8, 2006, Pages 1167-1177

  Kazuno, An A ^a,b   Munakata, Kae ^a   Nagai, Takeharu ^a,c,f   Shimozono, Satoshi ^a   Tanaka, Masashi ^d   Yoneda, Makoto ^e   Kato, Nobumasa ^b   Miyawaki, Atsushi ^a   Kato, Tadafumi ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^e UNIVERSITY OF FUKUI   (Japan)

^f HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HISTAMINE; MITOCHONDRIAL DNA;

ADULT; ALZHEIMER DISEASE; ARTICLE; BIPOLAR DISORDER; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CANCER; CELL NUCLEUS; CELL PH; CONTROLLED STUDY; CYBRID; CYTOSOL; DNA POLYMORPHISM; DNA SEQUENCE; EXTRACELLULAR MATRIX; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HYBRID CELL; MALE; MITOCHONDRION; PARKINSON DISEASE; PATHOPHYSIOLOGY; RISK FACTOR; SEQUENCE ANALYSIS; GENETIC POLYMORPHISM; GENETICS; METABOLISM; PH;

ALZHEIMER DISEASE; CALCIUM; DNA, MITOCHONDRIAL; HUMANS; HYDROGEN-ION CONCENTRATION; PARKINSON DISEASE; POLYMORPHISM, GENETIC;

EID: 33748087125     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.0020128     Document Type: Article

References (59)

1. Hansford RG, Zorov D (1998) Role of mitochondrial calcium transport in the control of substrate oxidation. Mol Cell Biochem 184: 359-369.
2. Cortassa S, Aon MA, Marban E, Winslow RL, O'Rourke B (2003) An integrated model of cardiac mitochondrial energy metabolism and calcium dynamics. Biophys J 84: 2734-2755.
3. Demaurex N, Distelhorst C (2003) Cell biology. Apoptosis - The calcium connection. Science 300: 65-67.
4. Hajnoczky G, Davies E, Madesh M (2003) Calcium signaling and apoptosis. Biochem Biophys Res Commun 304: 445-454.
5. Rizzuto R, Pinton P, Ferrari D, Chami M, Szabadkai G, et al. (2003) Calcium and apoptosis: Facts and hypotheses. Oncogene 22: 8619-8627.
6. Kaftan EJ, Xu T, Abercrombie RF, Hille B (2000) Mitochondria shape hormonally induced cytoplasmic calcium oscillations and modulate exocytosis. J Biol Chem 275: 25465-25470.
7. Medler K, Gleason EL (2002) Mitochondrial Ca(2+) buffering regulates synaptic transmission between retinal amacrine cells. J Neurophysiol 87: 1426-1439.
8. Weeber EJ, Levy M, Sampson MJ, Anflous K, Armstrong DL, et al. (2002) The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. J Biol Chem 277: 18891-18897.
9. Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119: 873-887.
10. Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, et al. (1981) Sequence and organization of the human mitochondrial genome. Nature 290: 457-465.
11. Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348: 651-653.
12. Kobayashi Y, Momoi MY, Tominaga K, Momoi T, Nihei K, et al. (1990) A point mutation in the mitochondrial tRNA(Leu)(UUR) gene in MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes). Biochem Biophys Res Commun 173: 816-822.
13. Hess JF, Parisi MA, Bennett JL, Clayton DA (1991) Impairment of mitochondrial transcription termination by a point mutation associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 351: 236-239.
14. Smeitink J, van den Heuvel L, DiMauro S (2001) The genetics and pathology of oxidative phosphorylation. Nat Rev Genet 2: 342-352.
15. Poulton J, Luan J, Macaulay V, Hennings S, Mitchell J, et al. (2002) Type 2 diabetes is associated with a common mitochondrial variant: Evidence from a population-based case-control study. Hum Mol Genet 11: 1581-1583.
16. Hutchin T, Cortopassi G (1995) A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci U S A 92: 6892-6895.
17. van der Walt JM, Dementieva YA, Martin ER, Scott WK, Nicodemus KK, et al. (2004) Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365: 28-32.
18. Shoffner JM, Brown MD, Torroni A, Lott MT, Cabell MF, et al. (1993) Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 17: 171-184.
19. van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, et al. (2003) Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet 72: 804-811.
20. Huerta C, Castro MG, Coto E, Blazquez M, Ribacoba R, et al. (2005) Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population. J Neurol Sci 236: 49-54.
21. Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, et al. (2005) Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet 13: 748-752.
22. Kato T, Kunugi H, Nanko S, Kato N (2001) Mitochondrial DNA polymorphisms in bipolar disorder. J Affect Disord 62: 151-164.
23. McMahon FJ, Chen YS, Patel S, Kokoszka J, Brown MD, et al. (2000) Mitochondrial DNA sequence diversity in bipolar affective disorder. Am J Psychiatry 157: 1058-1064.
24. Canter JA, Kallianpur AR, Parl FF, Millikan RC (2005) Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 65: 8028-8033.
25. Mims MP, Hayes TG, Zheng S, Leal SM, Frolov A, et al. (2006) Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res 66:: 1880; author reply 1880-1881.
26. Skuder P, Plomin R, McClearn GE, Smith DL, Vignetti S, et al. (1995) A polymorphism in mitochondrial DNA associated with IQ? Intelligence 21: 1-11.
27. Kato C, Umekage T, Tochigi M, Otowa T, Hibino H, et al. (2004) Mitochondrial DNA polymorphisms and extraversion. Am J Med Genet 128B: 76-79.
28. Tanaka M, Takeyasu T, Fuku N, Li-Jun G, Kurata M (2004) Mitochondrial genome single nucleotide polymorphisms and their phenotypes in the Japanese. Ann N Y Acad Sci 1011: 7-20.
29. Tanaka M, Gong J, Zhang J, Yamada Y, Borgeld HJ, et al. (2000) Mitochondrial genotype associated with longevity and its inhihitory effect on mutagenesis. Mech Ageing Dev 116: 65-76.
30. King MP, Attardi G (1989) Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 246: 500-503.
31. 2+. Proc Natl Acad Sci U S A 98: 3197-3202.
32. Filippin L, Magalhaes PJ, Di Benedetto G, Colella M, Pozzan T (2003) Stable interactions between mitochondria and endoplasmic reticulum allow rapid accumulation of calcium in a subpopulation of mitochondria. J Biol Chem 278: 39224-39234.
33. Frieden M, James D, Castelbou C, Danckaert A, Martinou JC, et al. (2004) Ca(2+) homeostasis during mitochondrial fragmentation and perinuclear clustering induced by hFis1. J Biol Chem 279: 22704-22714.
34. Llopis J, McCaffery JM, Miyawaki A, Farquhar MG, Tsien RY (1998) Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc Natl Acad Sci U S A 95: 6803-6808.
35. Porcelli AM, Ghelli A, Zanna C, Pinton P, Rizzuto R, et al. (2005) pH difference across the outer mitochondrial membrane measured with a green fluorescent protein mutant. Biochem Biophys Res Commun 326: 799-804.
36. Brini M, Pinton P, King MP, Davidson M, Schon EA, et al. (1999) A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nat Med 5: 951-954.
37. Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, et al. (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23: 147.
38. Elsliger MA, Wachter RM, Hanson GT, Kallio K, Remington SJ (1999) Structural and spectral response of green fluorescent protein variants to changes in pH. Biochemistry 38: 5296-5301.
39. Matsuyama S, Llopis J, Deveraux QL, Tsien RY, Reed JC (2000) Changes in intramitochondrial and cytosolic pH: Early events that modulate caspase activation during apoptosis. Nat Cell Biol 2: 318-325.
40. Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89: 5547-5551.
41. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
42. Baron U, Freundlieb S, Gossen M, Bujard H (1995) Co-regulation of two gene activities by tetracycline via a bidirectional promoter. Nucleic Acids Res 23: 3605-3606.
43. Mizuno H, Sawano A, Eli P, Hama H, Miyawaki A (2001) Red fluorescent protein from Discosoma as a fusion tag and a partner for fluorescence resonance energy transfer. Biochemistry 40: 2502-2510.
44. Bernardi P (1992) Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J Biol Chem 267: 8834-8839.
45. Trounce IA, Kim YL, Jun AS, Wallace DC (1996) Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol 264: 484-509.
46. Kato T (2001) DNA polymorphisms and bipolar disorder. Am J Psychiatry 158: 1169-1170.
47. Sudoyo H, Suryadi H, Lertrit P, Pramoonjago P, Lyrawati D, et al. (2002) Asian-specific mtDNA backgrounds associated with the primary G11778A mutation of Leber's hereditary optic neuropathy. J Hum Genet 47: 594-604.
48. Tanaka M, Gong JS, Zhang J, Yoneda M, Yagi K (1998) Mitochondrial genotype associated with longevity. Lancet 351: 185-186.
49. Matsunaga H, Tanaka Y, Tanaka M, Gong JS, Zhang J, et al. (2001) Antiatherogenic mitochondrial genotype in patients with type 2 diabetes. Diabetes Care 24: 500-503.
50. Takagi K, Yamada Y, Gong JS, Sone T, Yokota M, et al. (2004) Association of a 5178C→A (Leu237Met) polymorphism in the mitochondrial DNA with a low prevalence of myocardial infarction in Japanese individuals. Atherosclerosis 175: 281-286.
51. Dato S, Passarino G, Rose G, Altomare K, Bellizzi D, et al. (2004) Association of the mitochondrial DNA haplogroup J with longevity is population specific. Eur J Hum Genet 12: 1080-1082.
52. Niemi AK, Moilanen JS, Tanaka M, Hervonen A, Hurme M, et al. (2005) A combination of three common inherited mitochondrial DNA polymorphisms promotes longevity in Finnish and Japanese subjects. Eur J Hum Genet 13: 166-170.
53. Bentlage HA, Chomyn A (1996) Immunoprecipitation of human mitochondrial translation products with pep tide-specific antibodies. Methods Enzymol 264: 218-228.
54. Nishino I, Kobayashi O, Goto Y, Kurihara M, Kumagai K, et al. (1998) A new congenital muscular dystrophy with mitochondrial structural abnormalities. Muscle Nerve 21: 40-47.
55. 2+ based on green fluorescent proteins and calmodulin. Nature 388: 882-887.
56. Tanaka M, Hayakawa M, Ozawa T (1996) Automated sequencing of mitochondrial DNA. Methods Enzymol 264: 407-421.
57. Sawano A, Miyawaki A (2000) Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis. Nucleic Acids Res 28: E78.
58. Wachter RM, Elsliger MA, Kallio K, Hanson GT, Remington SJ (1998) Structural basis of spectral shifts in the yellow-emission variants of green fluorescent protein. Structure 6: 1267-1277.
59. Ormo M, Cubitt AB, Kallio K, Gross LA, Tsien RY, et al. (1996) Crystal structure of the Aequorea victoria green fluorescent protein. Science 273: 1392-1395.